98 related articles for article (PubMed ID: 10547031)
1. Lack of squamous cell lung carcinoma in vitro chemosensitivity to various drug regimens in the adenosine triphosphate cell viability chemosensitivity assay.
Vogt U; Striehn E; Bosse U; Klinke F; Falkiewicz B
Acta Biochim Pol; 1999; 46(2):299-302. PubMed ID: 10547031
[TBL] [Abstract][Full Text] [Related]
2. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
Tam KF; Ng TY; Tsang PC; Li CF; Ngan HY
J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
[TBL] [Abstract][Full Text] [Related]
3. p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
Vogt U; Zaczek A; Klinke F; Granetzny A; Bielawski K; Falkiewicz B
J Cancer Res Clin Oncol; 2002 Mar; 128(3):141-7. PubMed ID: 11935300
[TBL] [Abstract][Full Text] [Related]
4. [In vitro chemosensitivity of lung cancer and other chest tumors evaluated by human tumor colony assay].
Lee K; Kuze F; Hashimura T; Tanigawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2537-43. PubMed ID: 6095761
[TBL] [Abstract][Full Text] [Related]
5. [Update of human tumor clonogenic assay in carcinoma of the lung].
Kanzawa F
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer.
d'Amato TA; Landreneau RJ; McKenna RJ; Santos RS; Parker RJ
Ann Thorac Surg; 2006 Feb; 81(2):440-6; discussion 446-7. PubMed ID: 16427828
[TBL] [Abstract][Full Text] [Related]
8. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
Liu S; Qian X; Peng Z; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
[TBL] [Abstract][Full Text] [Related]
9. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
Bepler G; O'Briant K
Anticancer Res; 1998; 18(5A):3181-5. PubMed ID: 9858881
[TBL] [Abstract][Full Text] [Related]
10. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
[TBL] [Abstract][Full Text] [Related]
11. [Chemosensitivity test for unresectable non-small cell lung cancer].
Kawamura M; Inoue Y; Oyama T; Kobayashi K
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):229-32. PubMed ID: 11904985
[TBL] [Abstract][Full Text] [Related]
12. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
Ng TY; Ngan HY; Cheng DK; Wong LC
Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay].
Kurbacher CM; Brenne U; Kurbacher JA; Mallmann P; Krebs D
Zentralbl Gynakol; 1996; 118(5):271-8. PubMed ID: 8701623
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
15. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
Köchli OR; Sevin BU; Schär G; Haller U
Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
17. [Chemosensitivity testing of topotecan as second-line agent in chemotherapy of ovarian cancer].
Qian XL; Peng ZL; Liu SL
Ai Zheng; 2003 Dec; 22(12):1352-4. PubMed ID: 14693068
[TBL] [Abstract][Full Text] [Related]
18. [Expression of multidrug resistance-associated protein gene in non-small cell lung cancer].
Xu M; Li J; Xia Q
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):268-70. PubMed ID: 11775850
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
20. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
